20th Annual International Ultmann Chicago Lymphoma Symposium
April 21 - 22, 2023
Scientific innovation in the detection and treatment of lymphoma is rapidly advancing, and practicing physicians cannot keep abreast of the latest developments in the area. By educating healthcare providers on the current publications and lymphoma data, patients will receive the best and most relevant treatment of their disease.
- Debate the selection and sequencing of the latest advances to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma
- Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma
- Evaluate clinical trial data of current and emerging cellular therapy/CAR T-cell approaches for patients with lymphoma, including important safety and efficacy data
- Review specific patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL
- Acquire strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma
Accreditation and Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
University of Chicago Medicine is accredited as a provider of continuing nursing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 14.5 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professionals Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The staff of the Center for Continuing Medical Education, Bio Ascend, and Meeting Achievements have disclosed that they have no relevant financial relationships with ACCME defined commercial interests.